TrialBMC neurology2006

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.

Florian Then Bergh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.